Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
P. Chellapandi, S. Saranya
Medicinal Chemistry Research (2020) Vol. 29, Iss. 10, pp. 1777-1791
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Role of genomics in combating COVID-19 pandemic
K.A. Saravanan, Manjit Panigrahi, Harshit Kumar, et al.
Gene (2022) Vol. 823, pp. 146387-146387
Open Access | Times Cited: 52
D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity
Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 24, pp. 9035-9045
Open Access | Times Cited: 46
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage
Ya‐Wen Cheng, Tai‐Ling Chao, Chiao-Ling Li, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 40
Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study
Sumit Arora, Govind K. Lohiya, Keshav S. Moharir, et al.
Digital Chinese Medicine (2020) Vol. 3, Iss. 4, pp. 239-248
Open Access | Times Cited: 39
Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach
Alaka Sahoo, Shivkanya Fuloria, Shasank S. Swain, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1505-1505
Open Access | Times Cited: 30
Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2
Vikas Kumar, Shraddha Parate, Sanghwa Yoon, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 28
Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening
Oludare M. Ogunyemi, Gideon Ampoma Gyebi, Ibrahim M. Ibrahim, et al.
RSC Advances (2021) Vol. 11, Iss. 53, pp. 33380-33398
Open Access | Times Cited: 27
A rapid and cost‐effective multiplex ARMS‐PCR method for the simultaneous genotyping of the circulating SARS‐CoV‐2 phylogenetic clades
Md. Tanvir Islam, A. S. M. Rubayet Ul Alam, Najmuj Sakib, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 5, pp. 2962-2970
Open Access | Times Cited: 25
SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review
Yusuf Muhammed, Abduljalal Yusuf Nadabo, Mkpouto Pius, et al.
Biosafety and Health (2021) Vol. 3, Iss. 5, pp. 249-263
Open Access | Times Cited: 25
Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2
Anjani, Sumit Kumar, Brijesh Rathi, et al.
RSC Advances (2023) Vol. 13, Iss. 6, pp. 3677-3687
Open Access | Times Cited: 8
Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease
Candida Manelfi, Jonas Goßen, Silvia Gervasoni, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 797-797
Open Access | Times Cited: 18
Structural insights of key enzymes into therapeutic intervention against SARS-CoV-2
Munazza Shahid, Syed Shahzad‐ul‐Hussan
Journal of Structural Biology (2020) Vol. 213, Iss. 1, pp. 107690-107690
Open Access | Times Cited: 16
Exploration of Luteolin as Potential Anti-COVID-19 Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET and DFT Analysis
Waseem Ahmad Ansari, Tanveer Ahamad, Mohsin Ali Khan, et al.
Letters in Drug Design & Discovery (2021) Vol. 19, Iss. 8, pp. 741-756
Closed Access | Times Cited: 15
A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics
R. Prathiviraj, S. Saranya, Muruganantham Bharathi, et al.
Computers in Biology and Medicine (2021) Vol. 132, pp. 104315-104315
Open Access | Times Cited: 14
Systems medicine framework for repurposable drug combinations for COVID-19 comorbidities
S. Saranya, L. Thamanna, P. Chellapandi
Medicine in Omics (2024) Vol. 11, pp. 100038-100038
Open Access | Times Cited: 1
Deep Learning Algorithms Achieved Satisfactory Predictions When Trained on a Novel Collection of Anticoronavirus Molecules
Emna Harigua‐Souiai, Mohamed Mahmoud Heinhane, Yosser Zina Abdelkrim, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 11
Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2
Wei Chen, Zhihao Wang, Yawen Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 10
High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors
Bakhtyar Sepehri, Mohammad Kohnehpoushi, Raouf Ghavami
Journal of the Iranian Chemical Society (2021) Vol. 19, Iss. 5, pp. 1865-1876
Closed Access | Times Cited: 9
A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan
Ulykbek Kairov, Amina Amanzhanova, Daniyar Karabayev, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
SARS‐CoV‐2 main protease inhibitors: What is moving in the field of peptides and peptidomimetics?
Sergio Algar, M. Ángeles Bonache, Rosario González‐Muñiz
Journal of Peptide Science (2022) Vol. 29, Iss. 5
Open Access | Times Cited: 5
TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
Zeynep Sena Karahan, Mertkaya Aras, Tolga Sütlü
Turkish Journal of Hematology (2023)
Open Access | Times Cited: 2
Revealing the genotypic variants and proteomic mutations in Turkish SARS-CoV-2 driving evolution and virulence
R. Prathiviraj, K. Prinsha, Saqib Hassan, et al.
Medicine in Omics (2023) Vol. 9, pp. 100024-100024
Open Access | Times Cited: 2
In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2
M A. Siddiqa, D Rao, G. Suvarna, et al.
International Journal of Peptide Research and Therapeutics (2021) Vol. 27, Iss. 3, pp. 1633-1640
Open Access | Times Cited: 6
Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19
Marta Lucchetta, Marco Pellegrini
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Severity of severe acute respiratory syndrome coronavirus 2 and its impact on human health, with special reference to gut metabiome
Debanjan Mitra, Ishita Biswas, Pradeep K. Das Mohapatra
Elsevier eBooks (2024), pp. 163-178
Closed Access
Page 1 - Next Page

Scroll to top